Abstract
Background: Treatment non-response among high-risk, psychiatric patients exposes those suffering to suicidal risk as well as persistent social and occupational difficulties. Strategies for identification of treatment non-response are limited. Aims: Diagnostic efficiency of a self-report, cross-cutting symptom measure was assessed as a marker of treatment non-response. Method: 835 inpatients at a specialist psychiatric hospital completed the Patient Health Questionnaire - Depression (PHQ-9) at admission and every two weeks during hospitalization. Results: For patients admitted with severe depression (PHQ-9≥20), results indicated good accuracy of 2-week PHQ-9 change score in identifying treatment non-response (AUC=0.80, SE=0.04, p<.0001; sensitivity=85%; specificity=73%; OR=14.91). Conclusions: The search for predictors of non-response to psychiatric treatment has a long and generally unfulfilled history. The PHQ-9 change score holds promise as a cost-effective test with comparable diagnostic characteristics to other medical tests.
Original language | English (US) |
---|---|
Pages (from-to) | 114-119 |
Number of pages | 6 |
Journal | Journal of Psychiatric Research |
Volume | 68 |
DOIs | |
State | Published - Sep 1 2015 |
Keywords
- Diagnostic efficiency
- PHQ-9
- Prediction
- Treatment non-response
ASJC Scopus subject areas
- Psychiatry and Mental health
- Biological Psychiatry